MAPK pathway activation in pilocytic astrocytoma

DTW Jones, J Gronych, P Lichter, O Witt… - Cellular and Molecular …, 2012 - Springer
Pilocytic astrocytoma (PA) is the most common tumor of the pediatric central nervous system
(CNS). A body of research over recent years has demonstrated a key role for mitogen …

Clinicopathological relevance of BRAF mutations in human cancer

S Pakneshan, A Salajegheh, RA Smith… - Pathology-Journal of …, 2013 - journals.lww.com
BRAF represents one of the most frequently mutated protein kinase genes in human
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …

Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma

H Cin, C Meyer, R Herr, WG Janzarik, S Lambert… - Acta …, 2011 - Springer
Activation of the MAPK signaling pathway has been shown to be a unifying molecular
feature in pilocytic astrocytoma (PA). Genetically, tandem duplications at chromosome 7q34 …

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations

A Von Deimling, A Korshunov, C Hartmann - Brain Pathology, 2011 - Wiley Online Library
For some, glioma biomarkers have been expected to solve common diagnostic problems in
routine neuropathology service caused by insufficient material, technical shortcomings or …

BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549: BRAF Fusion Variants

A Lin, FJ Rodriguez, MA Karajannis… - … of Neuropathology & …, 2012 - academic.oup.com
Recent studies highlight the importance of BRAF alterations resulting in mitogen activated
protein kinase (MAK/ERK) pathway activation in low-grade CNS tumors. We studied 106 low …

Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas

C Horbinski, MN Nikiforova, JM Hagenkord… - Neuro …, 2012 - academic.oup.com
Abstract BRAF rearrangements and BRAF V600E point mutations are recurring events in
pediatric low-grade gliomas. However, their clinical significance, including possible …

Diagnostic, prognostic and predictive relevance of molecular markers in gliomas

S Brandner, A Von Deimling - Neuropathology and applied …, 2015 - Wiley Online Library
The advances of genome‐wide 'discovery platforms' and the increasing affordability of the
analysis of significant sample sizes have led to the identification of novel mutations in brain …

To BRAF or Not to BRAF: Is That Even a Question Anymore?

C Horbinski - Journal of Neuropathology & Experimental …, 2013 - academic.oup.com
Alterations in BRAF have been discovered in most pediatric low-grade gliomas. Because the
field has moved quickly during the past few years, there is not yet widespread awareness …

Current understanding of BRAF alterations in diagnosis, prognosis, and therapeutic targeting in pediatric low-grade gliomas

CL Penman, C Faulkner, SP Lowis, KM Kurian - Frontiers in oncology, 2015 - frontiersin.org
The mitogen-activated protein kinase (MAPK) pathway is known to play a key role in the
initiation and maintenance of many tumors as well as normal development. This often occurs …

Molecular diagnostics of gliomas

MN Nikiforova, RL Hamilton - Archives of pathology & …, 2011 - meridian.allenpress.com
Context.—Gliomas are the most common primary brain tumors of adults and include a
variety of histologic types and morphologies. Histologic evaluation remains the gold …